Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Ltd
Press Release Feb 12 2024
Business
Feb 12 2024
5 min read

Press Release Feb 12 2024

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 12, 2024, titled "Aurobindo Pharma receives USFDA Approval for Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg".

View Attachment